Product Information
REPAGLINIDE 1 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0937 per EA under NDC 33342024911. Its NADAC has been published 81 times since Oct 16, 2024.
FDA first approved this application on Mar 22, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342024911
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
REPAGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207209FDA Approved
3/22/2023
TE Code
AB
On Market Since
3/22/2023
Pharmacological Classes
Price Statistics
The NADAC for REPAGLINIDE 1 MG TABLET has been published 81 times since Oct 16, 2024, and over the history we have for it it has declined 20.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0937 per EA |
|---|---|
| All-time high | $0.1246 (Nov 13, 2024) |
| All-time low | $0.0800 (Mar 18, 2026) |
| 52-week high | $0.1067 |
| 52-week low | $0.0800 |
| Median price | $0.0991 |
| Average price | $0.1002 |
| Largest weekly change | -9.8% (Jul 23, 2025) |
| Weeks tracked | 81 |
| Tracking since | Oct 16, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of REPAGLINIDE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REPAGLINIDE 1 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0937 per EA (NDC 33342024911), effective Aug 19, 2026.
How has the price of REPAGLINIDE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for REPAGLINIDE 1 MG TABLET has declined 20.9%. It has been tracked across 81 weekly CMS publications since Oct 16, 2024.
What are the highest and lowest recorded NADAC prices for REPAGLINIDE 1 MG TABLET?
Since Oct 16, 2024, the NADAC for REPAGLINIDE 1 MG TABLET has ranged from a low of $0.0800 (Mar 18, 2026) to a high of $0.1246 (Nov 13, 2024), with a median of $0.0991 per EA.
Are there cheaper alternatives to REPAGLINIDE 1 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as REPAGLINIDE 1 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures REPAGLINIDE 1 MG TABLET?
REPAGLINIDE 1 MG TABLET (NDC 33342024911) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.